Chen Named Rowley Professor in Cancer Research
The University of Chicago Medicine Comprehensive Cancer Center
Jing Chen, PhD, an international leader in cancer metabolism, was recently named the first Janet Davison Rowley Professor in Cancer Research. Dr. Chen also serves as inaugural director of the newly established Cancer Metabolic Research Center.
Read More
Baumann Named to Four Cancer Advisory Committees
Siteman Cancer Center
Brian C. Baumann, MD, a radiation oncologist, has been chosen to serve on four national cancer advisory committees: National Association for Proton Therapy Physician Advisory Committee; National Cancer Institute Bladder Cancer Task Force; NRG Oncology Genitourinary Committee; and the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology Committee.
Read More
Cancer Center Members Named to National Breast Cancer Clinical Trials Task Force
The University of Kansas Cancer Center
Jamie Wagner, DO, FACOS, FACS, and Shane Stecklein, MD, PhD, have been appointed to the Breast Oncology Local Disease Task Force of the National Cancer Institute Breast Cancer Steering Committee. Their three-year terms began January 1.
Read More
V Foundation Awards Two Huntsman Researchers
Huntsman Cancer Institute at the University of Utah
Two researchers at Huntsman Cancer Institute at the University of Utah have received awards from the V Foundation for Cancer Research. Charles R. Rogers, PhD, MPH, MS, was awarded the 2020 V Scholar Grant, and Jennifer Doherty, PhD, MS, received the 2020 Robin Roberts Cancer Thrivership Research Award.
Read More
Abstract Named 2020 Best of ASTRO
University of Florida Health Cancer Center
The American Society for Radiation Oncology (ASTRO) Best of ASTRO Program Committee has selected an abstract by Raymond Mailhot Vega, MD, MPH, as a 2020 Best of ASTRO abstract.
Read More
Swartz Elected to the National Academy of Medicine
The University of Chicago Medicine Comprehensive Cancer Center
Melody Swartz, PhD, has been elected a member of the National Academy of Medicine. She was honored for "pioneering contributions" to the fields of lymphatic physiology, cancer research, and immunotherapy.
Read More
Back to News From the Centers
Brain Tumor Expert Appointed as New Deputy Director of Research
UPMC Hillman Cancer Center
UPMC Hillman Cancer Center recently announced the appointment of Jeremy Rich, MD, MHS, MBA, as deputy director of research. Dr. Rich will also serve as the Pittsburgh Foundation Chair in Personalized Cancer Therapy and a professor of neurology at the University of Pittsburgh School of Medicine.
Read More
Greenup Appointed Chief of Breast Surgical Oncology
Yale Cancer Center, Yale School of Medicine
Rachel Adams Greenup, MD, MPH, FACS, has been appointed as associate professor of surgery (oncology) and section chief of breast surgery for the Department of Surgery at Yale School of Medicine. She joins Yale from Duke University.
Read More
Sekeres Named New Physician Liaison in Hematology
Sylvester Comprehensive Cancer Center, University of Miami
Mikkael Sekeres, MD, MS, has joined the Sylvester Comprehensive Cancer Center team as the new physician liaison in hematology and chief of the Division of Hematology in the Department of Medicine.
Read More
D'Amico Named AATS Medical Director
Duke Cancer Institute, Duke University Medical Center
Thomas A. D’Amico, MD, chief of General Thoracic Surgery and director of the Thoracic Oncology program at Duke Cancer Institute, has been appointed to a two-year term as medical director of the American Association for Thoracic Surgery (AATS).
Read More
Associate Director of Cancer Health Equity and Community Engagement Named
Stanford Cancer Institute
Alyce Adams, PhD, has been named the inaugural associate director of Stanford Cancer Institute’s Office of Cancer Health Equity and Community Engagement. Her research focuses primarily on the determinants of suboptimal use of health care services among older adults with chronic conditions; racial differences in medication adherence; and the impact of health policy changes on access to quality care.
Read More
Chief Nursing Officer and Vice President of Nursing and Patient Services Named
Fox Chase Cancer Center, Temple Health
Fox Chase Cancer Center announces the recruitment of Anna Liza Rodriguez, MSN, MHA, RN, OCN®, NEA-BC, as chief nursing officer and vice president of nursing and patient services. She served for nearly five years as associate nursing officer at Vanderbilt-Ingram Cancer Center before joining Fox Chase.
Read More
Rogers Named Director of Kentucky Cancer Program
UK Markey Cancer Center
UK Markey Cancer Center has announced the appointment of Mindy Rogers as director of the Kentucky Cancer Program – East, which is housed within the cancer center.
Read More
City of Hope Taps First Chief Diversity, Equity, and Inclusion Officer
City of Hope Comprehensive Cancer Center
Angela L. Talton has joined City of Hope's executive leadership team as senior vice president and chief diversity, equity, and inclusion officer.
Read More
New Chief of Hematology and Oncology Announced
Hollings Cancer Center, Medical University of South Carolina
Craig Lockhart, MD, has been recruited as the new chief of the Division of Hematology & Oncology at the Medical University of South Carolina and will serve as associate director for clinical science at MUSC Hollings Cancer Center, effective April 1. Dr. Lockhart currently holds several roles at the University of Miami Sylvester Comprehensive Cancer Center.
Read More
Davis to Lead Health Data Science and AI
University of Colorado Cancer Center
Sean Davis, MD, PhD, who currently serves as a senior associate scientist at the National Cancer Institute, will serve as the new associate director for informatics and data science at the University of Colorado Cancer Center.
Read More
Chief of Blood Cancer Pathology Service Named
Duke Cancer Institute, Duke University Medical Center
Ken H. Young, MD, PhD, is the new chief of the Hematopathology Division and Duke Cancer Institute Blood Cancer Pathology Service. He directs a lab focused on the mechanisms of tumor progression and novel therapeutic strategies in lymphoma, myeloma, and leukemia. Dr. Young joined Duke in 2019 from The University of Texas MD Anderson Cancer Center.
Read More
Kim to Direct Women's Cancer Program
Cedars-Sinai Cancer
Internationally prominent gynecologic oncologist Kenneth H. Kim, MD, recently was selected to direct the Division of Gynecologic Oncology at Cedars-Sinai Cancer. He also serves as chair of the cancer center's Committee for Oversight of Training and Education.
Read More
Helmke is New Chief Operating Officer
Fox Chase Cancer Center, Temple Health
Fox Chase Cancer Center announces the addition of Joel Helmke, MSHP, FACHE, to its senior leadership team as chief operating officer. Before joining Fox Chase, Helmke served nearly five years as senior vice president of clinical operations at City of Hope National Medical Center.
Read More
Hinrichs Named to Build Cancer Immunology and Immunotherapy Programs
Rutgers Cancer Institute of New Jersey
Christian Hinrichs, MD, has been named chief of the Section of Cancer Immunotherapy and co-director of the Cancer Immunology and Metabolism Center of Excellence. Dr. Hinrichs was recruited from the National Cancer Institute where he served as a tenured senior investigator in the Genitourinary Malignancies Branch.
Read More
New Director for Cell Therapy Laboratory Announced
UPMC Hillman Cancer Center
UPMC Hillman Cancer Center has announced that Yen-Michael Hsu, MD, PhD, will serve as the new director of the Immunologic Monitoring and Cellular Therapeutics Laboratory.
Read More
Back to News From the Centers
Gut Microbe May Promote Breast Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
A microbe found in the colon and commonly associated with the development of colitis and colon cancer also may play a role in the development of some breast cancers, according to new research from investigators with the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy.
Read More
Proteogenomics Offers Insight to Treating Head and Neck Squamous Cell Carcinoma
Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine
Proteogenomic analysis may offer new insight into matching cancer patients with an effective therapy for their particular cancer. A new study identifies three molecular subtypes in head and neck squamous cell carcinoma that could be used to better determine appropriate treatment. The research was led by Baylor College of Medicine, Johns Hopkins University, and the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium.
Read More
Gene Sequencing Used to Quantify Risk of Skin Cancer Long Before Damage is Visible
Roswell Park Comprehensive Cancer Center
Research conducted by a team at Roswell Park Comprehensive Cancer Center sheds light on the carcinogenic effect of exposure to ultraviolet (UV) radiation. A new study details a method to measure the abundance of cancer-related early changes to skin tissue long before the damage becomes visible to the eye.
Read More
Aggressive Breast Cancers in Black Patients Related to Immune Factors
Roswell Park Comprehensive Cancer Center
Rates of death from breast cancer are 40 percent higher in Black women than in white women. Research shows the tumors in Black women are more aggressive, but experts did not know why. New research from Roswell Park shows the aggressive cancer is related to a greater number of "exhausted" immune cells.
Read More
Machine Learning Potential to Predict Cancer Therapy-Related Cardiac Risk Shown
Case Comprehensive Cancer Center
Machine learning-based approaches to risk assessment can be highly effective in predicting various types of cardiac dysfunction among cancer survivors who have received cardiotoxic cancer therapies, according to a new retrospective longitudinal study by researchers from Cleveland Clinic’s Lerner Research Institute; Heart, Vascular & Thoracic Institute; and Taussig Cancer Institute.
Read More
Unique Review of National Data Aims to Better Understand Geographic Factors Affecting HPV Vaccination Rates
VCU Massey Comprehensive Cancer Center
Bernard Fuemmeler, PhD, and his team have conducted the first-ever systematic review of area-level data reported in the United States between 2006 and 2020 to determine how geography, neighborhoods, and sociodemographic factors impact HPV vaccination rates among adolescents and young adults.
Read More
Older Minority Cancer Patients Have Worse Surgical Outcomes Compared to White Patients With Similar Socioeconomic Factors
The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute
Older minority cancer patients with poor social determinants of health are significantly more likely to experience negative surgical outcomes compared to white patients with similar risk factors, according to a new study published by researchers at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute.
Read More
Researchers Create Comprehensive Multiomic Resource for Head and Neck Cancers
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
In what is believed to be the most comprehensive molecular characterization to date of the most common type of head and neck cancer, researchers from the Johns Hopkins departments of pathology and oncology, the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine, and 18 other centers around the U.S. and Poland have clarified the contribution of key cancer-associated genes, proteins, and signaling pathways in these cancers.
Read More
Understanding Kava's Role as a Cancer Suppressant
University of Florida Health Cancer Center
If there’s one piece of advice Chengguo "Chris" Xing, PhD, would give you, it’s to "stress less." Dr. Xing, a UF Health Cancer Center member, sees stress as the culprit in various health conditions: insomnia, anxiety, tobacco cravings — even cancer. He’s been evaluating piper methysticum, better known as kava, for its potential to help manage all of these.
Read More
Unusual Colon Discovery Explains Racial Disparities in Colorectal Cancer
University of Virginia Cancer Center
The colons of African Americans and people of European descent age differently, new research reveals. Scientists at the University of Virginia found that one side of the colon ages biologically faster than the other in both African Americans and people of European descent. In African Americans, however, the right side ages significantly faster, explaining why African Americans are more likely to develop cancerous lesions on the right side and why they are more likely to suffer colorectal cancer at a younger age.
Read More
Inflammation From Androgen Deprivation Therapy May Cause Fatigue in Prostate Cancer Patients
Moffitt Cancer Center
Moffitt Cancer Center researchers are investigating whether inflammation in the body, a side effect of androgen deprivation therapy, contributes to symptoms such as fatigue, depression, and cognitive impairment in prostate cancer patients. In a new study they pinpoint a specific inflammation marker that is associated with increased fatigue in this group of patients.
Read More
Mediterranean Diet May Decrease Risk of Prostate Cancer Progression for Men on Active Surveillance
The University of Texas MD Anderson Cancer Center
Examining a Mediterranean diet in relation to prostate cancer progression in men on active surveillance, researchers from The University of Texas MD Anderson Cancer Center found that men with localized prostate cancer who reported a baseline dietary pattern that more closely follows the key principles of a Mediterranean-style diet fared better over the course of their disease.
Read More
Key Pathway for Activated T Cells Might Be Targeted to Fight GVHD
University of Michigan Rogel Cancer Center
A new understanding of intracellular pathways activated as T cells start to mount an immune response offers clues against graft-versus-host disease, a serious complication of bone marrow transplantation.
Read More
Investigational Combo Therapy Shows Benefit for TP53 Mutant MDS and Acute Myeloid Leukemia Patients
Moffitt Cancer Center
David Sallman, MD, is leading a national, multicenter clinical trial investigating a new therapy option for patients with TP53-mutant disease. It builds upon the standard of care therapy, combining eprenetapopt with the chemotherapy azacitidine. Eprenetapopt is a first-in-class mutant p53 reactivator. It is infused in the body and induces cell death in TP53 mutant cancer cells.
Read More
Study Shows Kentucky Endometrial Cancer Patients Have Higher Rates of DACH1 Mutation
UK Markey Cancer Center
A new study by UK Markey Cancer Center researchers shows that DACH1 mutations are prevalent in Kentucky patients with endometrial cancer, suggesting that DACH1 may be a candidate biomarker for future trials with immunotherapy.
Read More
Youth Using E-cigarettes Three Times as Likely to Become Daily Cigarette Smokers
UC San Diego Moores Cancer Center
An analysis of a large nationally representative longitudinal study reports that starting tobacco products, including e-cigarettes, before the age of 18 is a major risk factor for people becoming daily cigarette smokers.
Read More
Arthritis Drug May Treat Immunotherapy-Related Heart Complication
Vanderbilt-Ingram Cancer Center
A drug typically prescribed for rheumatoid arthritis may also be effective in treating a rare but potentially deadly heart complication some cancer patients experience after taking immunotherapies, according to a study co-led by investigators at Vanderbilt University Medical Center.
Read More
'Biological Clock' an Unexpected and Novel Target for Prostate Cancer
Sidney Kimmel Cancer Center at Jefferson Health
Studies have shown that when circadian rhythms are disturbed there is an increased incidence of some cancers including prostate cancer. With an urgent need to develop novel therapeutic targets for prostate cancer, researchers at the Sidney Kimmel Cancer at Jefferson Health explored the circadian clock and found an unexpected role for the clock gene CRY-1 in cancer progression.
Read More
Findings Could Reduce Treatment-Related Complication for Blood Cancer Patients
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Researchers at the Indiana University Melvin and Bren Simon Comprehensive Cancer Center published promising findings on preventing a common complication to lifesaving blood stem cell transplantation in leukemia. Sherif Farag, MD, PhD, found that using a drug approved for type 2 diabetes reduces the risk of acute graft-versus-host disease.
Read More
Study Defines Small-Cell Lung Cancer Subtypes and Distinct Therapeutic Vulnerabilities for Each Type
The University of Texas MD Anderson Cancer Center
Researchers from The University of Texas MD Anderson Cancer Center have developed the first comprehensive framework to classify small-cell lung cancer into four unique subtypes, based on gene expression, and have identified potential therapeutic targets for each type.
Read More
Study Explains Why Patients With Cancer Spread to the Liver Have Worse Outcomes
University of Michigan Rogel Cancer Center
Michael Green, MD, PhD, noticed that when his patients had cancer that spread to the liver, they fared worse than when cancer spread to other parts of the body – and immunotherapy treatments had little impact. A new study finds that tumors in the liver siphon off critical immune cells, rendering immunotherapy ineffective. But coupling immunotherapy with radiotherapy to the liver in mice restored the immune cell function.
Read More
Study Reveals How Improved Type of Light Therapy Kills Precancerous Cells
Case Comprehensive Cancer Center
Researchers in the Department of Biomedical Engineering at Cleveland Clinic Lerner Research Institute have developed an improved approach to treating actinic keratosis, a precancerous skin condition usually treated with photodynamic therapy that patients often report as painful.
Read More
Triggering Tumor Antiviral Immune Response in Triple Negative Breast Cancer
Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine
Researchers at Baylor College of Medicine have discovered how therapeutics targeting RNA splicing can activate antiviral immune pathways in triple negative breast cancers to trigger tumor cell death and signal the body’s immune response.
Read More
Back to News From the Centers
Tobacco Treatment Training Program Earns Elite Accreditation
The University of Kansas Cancer Center
The University of Kansas Tobacco Treatment Specialist training program has been accredited by the Council for Tobacco Treatment Training Programs, joining just 23 other such accredited programs in the world. Babalola Faseru, MD, MPH, helps lead the program.
Read More
Community Advisory Board: Champions for Health Equity
UCSF Helen Diller Family Comprehensive Cancer Center
Over the past 15 years, the cancer center’s Community Advisory Board (CAB) has become one of UCSF’s most instrumental community outreach groups for improving health equity. In a Q&A, CAB Chair Arnold Perkins and Kim Rhoads, MD, MS, MPH, discuss why CABs are critical to the work of NCI cancer centers and the communities they serve.
Read More
Fourth Affiliate Joins Siteman Cancer Network
Siteman Cancer Center
The Siteman Cancer Network, an affiliation between Siteman Cancer Center and regional medical centers, has added a fourth member, the network’s second in Illinois. Carterville-based SIH Cancer Institute has joined the network, which aims to improve the health of people and communities through cancer prevention, research, and access to specialized treatment, when necessary, at Siteman in St. Louis.
Read More
Back to News From the Centers